Press release
Astellas decides to implement Werum's PAS-X
Astellas site in Meppel, The Netherlands
Astellas is implementing PAS-X as an EBR (Electronic Batch Recording) at its Dutch production site in Meppel. PAS-X will be set up in Astellas’ pharmaceutical solids production and packaging departments. The project includes PAS-X Business Functions Master Batch Records, Electronic Batch Recording, Weighing & Dispensing, Material Tracking, plus KPI functions. In addition, PAS-X is integrated in Astellas’ overall IT environment.
Astellas is the second-largest pharmaceutical group in Japan with three European production sites, the Dutch site in Meppel and two sites in Ireland. The Meppel site was built in 1995 and expanded in 2000. It will become Astellas’ pioneer for implementing an EBR system.
Werum is the international leading supplier of Manufacturing Execution Systems (MES) for the pharmaceutical and biopharmaceutical industries. Its successful and well-established MES product PAS-X is installed at 16 of the world’s top 30 pharmaceutical and biotech companies. The comprehensive range of functions built into PAS-X is the key to quality and compliance and lays the foundation for operational excellence initiatives in the manufacturing and packaging of pharmaceutical products. The company’s MES-related services include consulting, project management, validation support, system integration, training, maintenance, hotline support, and life cycle management. The software provider supplies turnkey, integrated and ready-to-be-validated Manufacturing Execution Systems. A global network of local Werum offices and carefully selected regional solution partners guarantees reliable on-site support for clients. Founded in 1969, the IT company currently employs 380 people at its headquarters in Lueneburg, Germany, and at eight other locations in Germany, France, the United States, Japan, and Singapore.
Werum Software & Systems
Wulf-Werum-Strasse 3
21337 Lueneburg, Germany
Press Contact:
Volker Mensing
Director Corporate Communications
Tel. +49 4131 8900-689
E-mail: mensing@werum.com
U.S. Contact:
Jude Andrade
Director Sales & Marketing
Phone: 973.644.4000 (x28)
E-mail: jude.andrade@werum.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Astellas decides to implement Werum's PAS-X here
News-ID: 107801 • Views: …
More Releases from Werum Software & Systems
13th PAS-X User Group Meeting in Germany
13th PAS-X User Group Meeting in Germany
Werum Manufacturing IT Conference with record attendance
Lueneburg, Germany, 26 October 2011 – The 13th international PAS-X User Group Meeting took place from 13 to 14 October 2011 in Lueneburg, Germany, with a record attendance. On the invitation of Werum Software & Systems AG, almost 200 pharmaceuticals experts from approximately 20 countries exchanged their thoughts and ideas on the use of the PAS-X production management…
Indian pharmaceutical major Dr. Reddy's chooses to implement Werum's MES
Dr. Reddy's Laboratories Ltd. deploys PAS-X at Hyderabad site
Lueneburg, Germany, August 20, 2010 – Dr. Reddy's Laboratories Ltd. has decided to introduce PAS-X, the Manufacturing Execution System (MES) by Werum Software & Systems, at its site in Bachupally, Hyderabad.
Dr. Reddy's plans to optimize the efficiency, quality, compliance and performance of its production processes with PAS-X. Werum is the leading supplier of MES systems for the pharmaceutical and biopharmaceutical industries…
MSD Packaging Lines run with PAS-X
Lueneburg, Germany, August 17, 2010 - MSD deployed PAS-X, the Manufacturing Execution System (MES) by Werum Software & Systems, to run its packaging line operations in Heist-op-den-Berg, Belgium in order to increase the compliance level during packaging operations and subsequently shorten lead times to improve delivery performance. Operations include fully automated blister lines and filling lines, semi-automated packaging lines and manual packaging processes. The project for introducing PAS-X was completed…
Successful rollout of PAS-X MES Weighing & Dispensing at AstraZeneca in India an …
Manufacturing Execution System projects completed successfully
Lueneburg, Germany, March 25, 2010 - Manufacturing Execution System (MES) software provider Werum Software & Systems has successfully finalized the installation of PAS-X MES in AstraZeneca's Wuxi site in the Jiangsu Province, China. This first-time MES project in the Chinese pharmaceutical industry follows an employment of Werum's PAS-X MES software in AstraZeneca's Indian production site in Bengaluru (formerly Bangalore) in 2009.
Both MES projects are part…
More Releases for Astellas
OAB Treatment Market 2020 Productivity Data Analysis by Key Company's (Astellas …
Global OAB Treatment Market: Overview
The overactive bladder treatment market includes various therapies, namely, anticholinergics, mirabegron, BOTOX, and neurostimulation used to treat the sudden, involuntary contraction of the muscle in the urinary bladder wall leading to urinary urgency, frequency, nocturia, and urge-incontinence
Get Access to Report Sample @ https://www.businessindustryreports.com/sample-request/240473
Global OAB Treatment Market: Growth Factors
The growth of market is majorly driven by the increasing geriatric population and consequently rising prevalence of bladder overactivity,…
What's driving the Diabetic Neuropathy Market Growth? Prominent Players: Pfizer, …
The Global Diabetic Neuropathy Market to gain from rapid technological advancements taking place in the market. Recently Fortune Business Insights has published a report, titled Diabetic Neuropathy Market Size, Share And Global Trend By Type (Peripheral, Proximal, Autonomic, Focal), By Drug Class (Non-steroidal Anti-inflammatory Drugs, Antisiezure Drugs, Opioid Drugs, Anti-depressants), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And Geography Forecast Till 2026.
Browse Full Report@ https://www.fortunebusinessinsights.com/industry-reports/diabetic-neuropathy-market-100598
Top Key Players Covered:
Company…
Primary Immunodeficiency Diseases Treatment Market | Astellas, AstraZeneca, Baxt …
HTF MI comprehensive and detailed 101-page research study on Global Primary Immunodeficiency Diseases Treatment provides a significantly expanded scope with deeply analyzed conclusions and content that includes an industry relevant database of major existing Primary Immunodeficiency Diseases Treatment manufacturers/players in each region, analysis of 11 leading national markets, important regions [United States, EU, Japan, China, India & Southeast Asia], a description of major geopolitical trends, analysis of the influencing factors…
Pertussis Vaccine Market Report for Period 2011 till 2023 Mitsubishi Tanabe Phar …
Global Pertussis Vaccine market report provides detailed analysis of companies namely Life Sciences, Beijing Tiantan, Biological Products, Chengdu Institute of, Biological Products, Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Astellas Pharma, Minhai Biotechnology, Wuhan Institute of, Biological Products, Changchun Changsheng and Others. This report study includes global market statistics and analysis for example, company performance, historical analysis 2012 to 2016, market forecast 2017 to 2023 in terms of volume, revenue, YOY…
Tacrolimus Market 2017- Astellas, Novartis, Hisun
Marketreports.biz, recently published a detailed market research study focused on the "Tacrolimus Market" across the global, regional and country level. The report provides 360° analysis of "Tacrolimus Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Tacrolimus industry, and estimates the future trend of Tacrolimus market on the basis of this…
Next Astellas Site will Implement Werum’s PAS-X
Next Astellas Site will Implement Werum’s PAS-X
One of the leading Japanese pharma groups chooses Werum again
Lueneburg, Germany, 24 April 2012 – Astellas Ireland Co. Ltd. (Kerry Plant) has decided to implement Werum´s PAS-X MES at its production facility in Killorglin, County Kerry, Ireland. The MES will introduce efficient and state-of-the-art paperless Electronic Batch Recording functionality supporting compliant, efficient and lean production processes. The MES will be fully integrated with the…
